1 Zhang FL,Li DQ.Targeting chromatin-remodeling factors in cancer cells:promising molecules in cancer therapy[J].Int J Mol Sci,2022,23(21):12815. 2 Wu L,Liu C,Hu W.Comprehensive investigation of matrix metalloproteinases in skin cutaneous melanoma:diagnostic,prognostic,and therapeutic insights[J].Sci Rep,2025,15(1):2152. 3 Liu J,Luo B,Zhang P,et al.Necroptosis-related lncRNAs in skin cutaneous melanoma:evaluating prognosis,predicting immunity,and guiding therapy[J].BMC Cancer,2023,23(1):752. 4 Cai Y,Wu S,Jia Y,et al.Potential key markers for predicting the prognosis of gastric adenocarcinoma based on the expression of ferroptosis-related lncRNA[J].J Immunol Res,2022,2022:1-17. 5 Hou W,Kong L,Hou Z,et al.CD44 is a prognostic biomarker and correlated with immune infiltrates in gastric cancer[J].BMC Med Genomics,2022,15(1):225. 6 Zhuang K,Wang L,Lu C,et al.Assessment of SWI/SNF chromatin remodeling complex related genes as potential biomarkers and therapeutic targets in pan-cancer[J].Mol Cancer,2024,23(1):176. 7 Helming KC,Wang X,Roberts CWM.Vulnerabilities of mutant SWI/SNF complexes in cancer[J].Cancer Cell,2014,26(3):309-317. 8 Yuan W,Zhang Q,Zhao Y,et al.BAP1 regulates HSF1 activity and cancer immunity in pancreatic cancer[J].J Exp Clin Canc Res,2024,43(1):275. 9 Dreier MR,De La Serna IL.SWI/SNF chromatin remodeling enzymes in melanoma[J].Epigenomes,2022,6(1):10. 10 Chen J,Yu N,Ou S,et al.Integrated analysis reveals SMARCD1 is a potential biomarker and therapeutic target in skin cutaneous melanoma[J].J Cancer Res Clin Oncol,2023,149(13):11619-11634. 11 Charoentong P,Finotello F,Angelova M,et al.Pan-cancer immunogenomic analyses reveal genotype-immunophenotype relationships and predictors of response to checkpoint blockade[J].Cell Rep,2017,18(1):248-262. 12 Tian J,Zhang L,Shi K,et al.The role of mitophagy-related genes in prognosis and immunotherapy of cutaneous melanoma:a comprehensive analysis based on single-cell RNA sequencing and machine learning[J].Immunol Res,2025,73(1):30. 13 Liu Y,Li C,Deng W.Uncovering the heterogeneity of signaling pathways in skin cutaneous melanoma:insights into prognostic values and immune interactions[J].Clin Cosmet Investig Dermatol,2025,Volume 18:47-59. 14 Peng K,Zhang Y,Liu D,et al.MMP2 is a immunotherapy related biomarker and correlated with cancer-associated fibroblasts infiltrate in melanoma[J].Cancer Cell Int,2023,23(1):26. 15 Zaman S,Chobrutskiy BI,Patel JS,et al.Potential MMP2-mediated availability of HLA binding,mutant ECM peptides reflects better melanoma survival rates and greater T-cell infiltrates[J].Lab Invest,2019,99(9):1287-1295. 16 Yin M,Zhang Y,Wang W,et al.Identification of two molecularly and prognostically distinct subtypes in acral melanoma using network prediction method[J].J Eur Acad Dermatol Venereol,2024:jdv.20335. 17 Zhang Z,Huang L,Li J,et al.Bioinformatics analysis reveals immune prognostic markers for overall survival of colorectal cancer patients:a novel machine learning survival predictive system[J].BMC Bioinf,2022,23(1):124. 18 Tian Z,Ou G,Su M,et al.TIMP1 derived from pancreatic cancer cells stimulates Schwann cells and promotes the occurrence of perineural invasion[J].Cancer Lett,2022,546:215863. 19 Yang E,Ding Q,Fan X,et al.Machine learning modeling and prognostic value analysis of invasion-related genes in cutaneous melanoma[J].Comput Biol Med,2023,162:107089. 20 Qiu X,Quan G,Ou W,et al.Unraveling TIMP1:a multifaceted biomarker in colorectal cancer[J].Front Genet,2023,14:1265137. 21 Shin Y,Kim S,Ghate NB,et al.MMP-9 drives the melanomagenic transcription program through histone H3 tail proteolysis[J].Oncogene,2022,41(4):560-570. 22 Tian Y,Guo Y,Zhu P,et al.TRIM59 loss in M2 macrophages promotes melanoma migration and invasion by upregulating MMP-9 and Madcam1[J].Aging,2019,11(19):8623-8641. 23 Sun S,Zhi Z,Su Y,et al.A CD8+T cell-associated immune gene panel for prediction of the prognosis and immunotherapeutic effect of melanoma[J].Front Immunol,2022,13:1039565. |